← FDA Drug Approvals (Drugs@FDA)
FEBUXOSTAT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2019-12-30
Drug application
- FDA Application #
ANDA210292- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FEBUXOSTAT
- Generic name
- FEBUXOSTAT
- Active ingredients
- FEBUXOSTAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- Manufacturer
- Tris Pharma Inc
- First approval
- 2019-12-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown